NCT01094860 2020-02-11Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Nelarabine in Patients With Relapsed/Refractory Lymphoid MalignanciesM.D. Anderson Cancer CenterPhase 1 Completed29 enrolled
NCT00406757 2017-11-13Clinical Evaluation of Nelarabine (506U78)in Japanese Patients With Leukemia or LymphomaGlaxoSmithKlinePhase 1 Completed13 enrolled
NCT00004239 2016-07-04506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver ImpairmentAlliance for Clinical Trials in OncologyPhase 1 Terminated10 enrolled